首页> 外文OA文献 >PMS21 Economic Outcomes For Celecoxib In Latin America: A Cost-Effectiveness Study Of Cox-2 Inhibitors Against Nsaids+Ppi For Adult Patients With Osteoarthritis And Rheumatoid Arthritis In Brazil, Mexico, Colombia, Argentina And Costa Rica

【2h】

PMS21 Economic Outcomes For Celecoxib In Latin America: A Cost-Effectiveness Study Of Cox-2 Inhibitors Against Nsaids+Ppi For Adult Patients With Osteoarthritis And Rheumatoid Arthritis In Brazil, Mexico, Colombia, Argentina And Costa Rica

机译：PMS21在拉丁美洲的Celecoxib的经济成果：在巴西，墨西哥，哥伦比亚，阿根廷和哥斯达黎加的成年骨关节炎和类风湿关节炎患者针对Nsaids + Ppi的Cox-2抑制剂的成本-效果研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Mould-Quevedo J.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT) [J] . Angel Lanas, Brendan Delaney, Christopher J Hawkey, BMJ Open . 2013,第1期

机译：塞洛昔单抗与传统非甾体类抗炎药在骨关节炎或类风湿关节炎患者中进行的大型前瞻性，随机，开放，盲目的终点简化了安全性研究：标准治疗与塞来昔布预后试验（SCOT）的方案
2. Where Latin Americans are physically active, and why does it matter? Findings from the IPEN-adult study in Bogota, Colombia; Cuernavaca, Mexico; and Curitiba, Brazil [J] . Salvo Deborah, Sarmiento Olga L., Reis Rodrigo S., Preventive Medicine: An International Journal Devoted to Practice and Theory . 2017,第Suppla期

机译：拉丁美洲人身体活跃的地方，为什么这很重要？来自哥伦比亚波哥大的IPEN成人学习的调查结果; Cuernavaca，墨西哥; 和库里提巴，巴西
3. Where Latin Americans are physically active, and why does it matter? Findings from the IPEN-adult study in Bogota, Colombia; Cuernavaca, Mexico; and Curitiba, Brazil [J] . Salvo Deborah, Sarmiento Olga L., Reis Rodrigo S., Preventive Medicine: An International Journal Devoted to Practice and Theory . 2017,第期

机译：拉丁美洲人身体活跃的地方，为什么这很重要？来自哥伦比亚波哥大的IPEN成人学习的调查结果; Cuernavaca，墨西哥; 和库里提巴，巴西
4. The state of judicial independence of Latin America: A framework for evaluating judicial independence and the success or failure of judicial reforms (Argentina, Chile, Costa Rica, Mexico, Venezuela). [D] . Colon, Edgardo E. 2003

机译：拉丁美洲司法独立状况：评估司法独立性和司法改革成败的框架（阿根廷，智利，哥斯达黎加，墨西哥，委内瑞拉）。
5. The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico [O] . Dante Israel León-de la O, Halla Thorsteinsdóttir, José Víctor Calderón-Salinas 2012

机译：拉丁美洲健康生物技术研究的兴起：对阿根廷，巴西，智利，哥伦比亚，古巴和墨西哥的健康生物技术生产及其影响的科学计量分析
6. Growing Pains in Latin America: An Economic Growth Framework as Applied to Brazil, Colombia, Costa Rica, Mexico, and Peru - Edited by Liliana Rojas-Suarez [O] . Eduardo Correia de Souza 100

机译：拉丁美洲的痛苦增长：一种适用于巴西，哥伦比亚，哥斯达黎加，墨西哥和秘鲁的经济增长框架-莉莉安娜·罗哈斯·苏亚雷斯编辑
7. Latin America: R and D Spending Jumps in Brazil, Mexico, and Costa Rica. [R] . Hill, D. 2000

机译：拉丁美洲：巴西，墨西哥和哥斯达黎加的R和D支出增长。

PMS21 Economic Outcomes For Celecoxib In Latin America: A Cost-Effectiveness Study Of Cox-2 Inhibitors Against Nsaids+Ppi For Adult Patients With Osteoarthritis And Rheumatoid Arthritis In Brazil, Mexico, Colombia, Argentina And Costa Rica

著录项

相似文献

相关主题

期刊订阅